Heartflow, a medical technology firm, debuted on Nasdaq with a 58% increase above its IPO price, raising $316 million and achieving a $2.4 billion valuation, marking a significant ...
Johnson & Johnson expects to face $400 million in tariff costs this year, largely due to the trade war with China, affecting its medical technology units. CEO Joaquin Duato warns o...
GE HealthCare's stock fell 14% after China announced export controls on rare earth materials, critical for medical technology, amid escalating US-China trade tensions.
